Thank you for the home kits
Measurements included total cholesterol, HDL cholesterol, triglycerides, adiponectin, C-reactive protein (CRP), activity of plasminogen activator inhibitor (PAI-1), activity of tissue plasminogen activator (TPA), and insulin-like growth factor (IGF-1)
Reconstitute a GLOW-70 vial by adding 2.5 mL of BAC water That delivers a concentration of 28 mg/mL The resulting dose per injection: 2.8 mg 28 mg/mL = 0.1 mL or 10-units on a U-100 insulin syringe Each 70 mg vial of GLOW supplies 25 daily doses and remains within the 28-day refrigerated-use window
Common schedules include weekly for 46 weeks, then monthly maintenance, or bi-weekly depending on baseline B12 status and clinical goals
Medicine has learned hard lessons from past cure-alls that went awry
Cognitive Research Emerging interest in IGF-1 mediated neuroprotective signaling pathways